Versigent PLC (DUSE:C0L)
| Market Cap | 2.58B |
| Revenue (ttm) | 8.09B +4.7% |
| Net Income | 456.91M +23.4% |
| EPS | 6.56 |
| Shares Out | n/a |
| PE Ratio | 5.30 |
| Forward PE | 5.66 |
| Dividend | 0.11 (0.32%) |
| Ex-Dividend Date | Sep 4, 2026 |
| Volume | 1 |
| Open | 36.02 |
| Previous Close | 37.93 |
| Day's Range | 34.74 - 36.02 |
| 52-Week Range | 21.87 - 39.53 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About Versigent
Versigent PLC designs, manufactures, and distributes low- and high-voltage power electrical architectures. The company offers signal and data connectivity solutions, power distribution systems, high-voltage electrical distribution systems, and EV charging solutions. It serves automotive, commercial vehicle, energy and grid, and other industries. The company was founded in 2026 and is based in Schaffhausen, Switzerland. [Read more]
Financial Performance
In 2025, Versigent's revenue was $8.82 billion, an increase of 6.13% compared to the previous year's $8.31 billion. Earnings were $528.00 million, an increase of 29.41%.
Financial numbers in USD Financial StatementsNews
Versigent Earnings Call Transcript: Q3 2026
Q3 sales grew 7% and Adjusted EBITDA rose 11% amid weak automotive production and elevated launches. FY26 free cash flow guidance increased to $275-$325 million, while sales and EBITDA outlooks were refined largely for copper pass-throughs.
Versigent Earnings release: Q3 2026
Versigent released its Q3 2026 earnings on November 4, 2026, summarizing the period's financial results.
Versigent Slides: Q3 2026
Versigent has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 4, 2026.
Versigent Quarterly report: Q3 2026
Versigent has published its Q3 2026 quarterly earnings report on November 4, 2026.
Versigent reports Q3 adjusted EPS $1.91, consensus $1.71
Reports Q3 revenue $2.450B, consensus $2.42B. “Versigent’s (VGNT) strong Q3 performance reflects the resilience of our business model and disciplined execution amid significant launch activity, lower ...
Versigent narrows FY26 revenue view to $9.500B-$9.600B from $9.400B-$9.600B
Consensus is for FY26 revenue $9.52B. Narrows FY26 Adjusted EBITDA view to $970M-$1.010B from $950M-$1.030B; and raises Free Cash Flow view to $275M-$325M from $200M-$300M.
Versigent Reports Third Quarter 2026 Results
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its ...
Versigent price target raised to $53 from $52 at RBC Capital
RBC Capital raised the firm’s price target on Versigent (VGNT) to $53 from $52 and keeps an Outperform rating on the shares as part of a broader research note previewing…
Versigent price target lowered to $58 from $59 at Goldman Sachs
Goldman Sachs analyst Mark Delaney lowered the firm’s price target on Versigent (VGNT) to $58 from $59 and keeps a Buy rating on the shares as part of a broader…
Versigent Announces Third Quarter 2026 Earnings Call Details
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low- and high-voltage electrical architectures, today announced it will release...
Versigent price target raised to $54 from $50 at Argus
Argus analyst Bill Selesky raised the firm’s price target on Versigent (VGNT) to $54 from $50 and keeps a Buy rating on the shares after its Q2 earnings beat last…
Versigent price target raised to $65 from $60 at Evercore ISI
Evercore ISI analyst Chris McNally raised the firm’s price target on Versigent (VGNT) to $65 from $60 and keeps an Outperform rating on the shares.
Versigent downgraded to Equal-Weight from Outperform at Fox Advisors
Fox Advisors analyst Steven Fox downgraded Versigent (VGNT) to Equal-Weight from Outperform, citing both the stock’s recent outperformance and management approaching its second half outlook “from a so...
Versigent price target raised to $58 from $49 at TD Cowen
TD Cowen analyst Itay Michaeli raised the firm’s price target on Versigent (VGNT) to $58 from $49 and keeps a Buy rating on the shares. The firm said its solid…
Versigent price target raised to $54 from $50 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Versigent (VGNT) to $54 from $50 and keeps a Buy rating on the shares.
Versigent price target raised to $59 from $48 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Versigent (VGNT) to $59 from $48 and keeps a Buy rating on the shares.
Versigent upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Tom Narayan upgraded Versigent (VGNT) to Outperform from Sector Perform with a price target of $52, up from $41. The company, post spin, is showing the “strength…
Versigent Earnings Call Transcript: Q2 2026
Q2 saw 11% net sales growth and 25% adjusted EBITDA growth, with strong performance in the Americas and Asia Pacific offsetting EMEA softness. 2026 guidance was raised for net sales but EBITDA and cash flow guidance were reaffirmed, reflecting copper and FX impacts. Dividend was initiated and bookings reached $2.8 billion.
Versigent Earnings release: Q2 2026
Versigent released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Versigent Slides: Q2 2026
Versigent has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Versigent Quarterly report: Q2 2026
Versigent has published its Q2 2026 quarterly earnings report on August 4, 2026.
Versigent raises 2026 revenue view to $9.4B-$9.6B from $9.1B-$9.4B
2026 revenue consensus $9.31B. Backs 2026 adjusted EBITDA view $950M-$1.03B.
Versigent reports Q2 adjusted EPS $1.92, consensus $1.44
Reports Q2 revenue $2.44B, consensus $2.33B. “Versigent’s (VGNT) solid second-quarter results demonstrate our continued ability to unlock greater value, even in a dynamic environment,” said CEO Joseph...
Versigent Reports Second Quarter 2026 Results
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its ...
Versigent initiated with a Buy at Argus
Argus initiated coverage of Versigent (VGNT) with a Buy rating and $50 price target Versigent is a high-quality industrial technology company with significant margin expansion potential, supported by ...